![Bart Klein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bart Klein
Directeur/Bestuurslid bij The Netherlands Biotech Industry Association
Profiel
Bart Klein is currently the Director at The Netherlands Biotech Industry Association.
Prior to this, he worked as the Global Head-Intellectual Property & Licensing at Royal KPN NV.
He also worked as the Executive VP-Legal & Intellectual Property at Crucell NV from 2001 to 2012.
Before that, he was a Patent Attorney at Mogen International Nv and a Senior Patent Attorney at Gist-Brocades NV.
Additionally, he served as a Member-Supervisory Board at DCPrime BV.
Actieve functies van Bart Klein
Bedrijven | Functie | Begin |
---|---|---|
The Netherlands Biotech Industry Association | Directeur/Bestuurslid | - |
Eerdere bekende functies van Bart Klein
Bedrijven | Functie | Einde |
---|---|---|
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Algemeen Adviseur | 01-01-2012 |
Mogen International Nv
![]() Mogen International Nv Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Mogen International Nv is a Dutch company that specializes in medicinal chemicals and botanical products. The company is based in Leiden, the Netherlands. Mogen International was acquired by Zeneca Group Plc on May 01, 1997 for $74.96 million. | Corporate Officer/Principal | - |
Gist-Brocades NV | Corporate Officer/Principal | - |
ROYAL KPN N.V. | Corporate Officer/Principal | - |
DCPrime BV
![]() DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ROYAL KPN N.V. | Communications |
Bedrijven in privébezit | 5 |
---|---|
DCPrime BV
![]() DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Health Technology |
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
The Netherlands Biotech Industry Association | |
Gist-Brocades NV | |
Mogen International Nv
![]() Mogen International Nv Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Mogen International Nv is a Dutch company that specializes in medicinal chemicals and botanical products. The company is based in Leiden, the Netherlands. Mogen International was acquired by Zeneca Group Plc on May 01, 1997 for $74.96 million. | Health Technology |